Literature DB >> 11081987

Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.

V Darbinyan1, A Kteyan, A Panossian, E Gabrielian, G Wikman, H Wagner.   

Abstract

The aim of this study was to investigate the effect of repeated low-dose treatment with a standardized extract SHR/5 of rhizome Rhodiola rosea L, (RRE) on fatigue during night duty among a group of 56 young, healthy physicians. The effect was measured as total mental performance calculated as Fatigue Index. The tests chosen reflect an overall level of mental fatigue, involving complex perceptive and cognitive cerebral functions, such as associative thinking, short-term memory, calculation and ability of concentration, and speed of audio-visual perception. These parameters were tested before and after night duty during three periods of two weeks each: a) a test period of one RRE/placebo tablet daily, b) a washout period and c) a third period of one placebo/RRE tablet daily, in a double-blind cross-over trial. The perceptive and cognitive cerebral functions mentioned above were investigated using 5 different tests. A statistically significant improvement in these tests was observed in the treatment group (RRE) during the first two weeks period. No side-effects were reported for either treatment noted. These results suggest that RRE can reduce general fatigue under certain stressful conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081987     DOI: 10.1016/S0944-7113(00)80055-0

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  52 in total

1.  Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice.

Authors:  Laura Mattioli; Federica Titomanlio; Marina Perfumi
Journal:  Psychopharmacology (Berl)       Date:  2012-03-16       Impact factor: 4.530

2.  Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.

Authors:  Jun J Mao; Sharon X Xie; Jarcy Zee; Irene Soeller; Qing S Li; Kenneth Rockwell; Jay D Amsterdam
Journal:  Phytomedicine       Date:  2015-02-23       Impact factor: 5.340

3.  Neuroprotection against cobalt chloride-induced cell apoptosis of primary cultured cortical neurons by salidroside.

Authors:  Shuqiang Zhang; Xia Chen; Yumin Yang; Xinyang Zhou; Jie Liu; Fei Ding
Journal:  Mol Cell Biochem       Date:  2011-04-17       Impact factor: 3.396

4.  Dietary supplement with a combination of Rhodiola crenulata and Ginkgo biloba enhances the endurance performance in healthy volunteers.

Authors:  Zhang-jin Zhang; Yao Tong; Jun Zou; Pei-jie Chen; Ding-hai Yu
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

5.  Salidroside stimulates DNA repair enzyme Parp-1 activity in mouse HSC maintenance.

Authors:  Xue Li; Jared Sipple; Qishen Pang; Wei Du
Journal:  Blood       Date:  2012-03-16       Impact factor: 22.113

6.  Hepatoprotective effect of Rhodiola imbricata rhizome against paracetamol-induced liver toxicity in rats.

Authors:  Ravichandran Senthilkumar; Rahul Chandran; Thangaraj Parimelazhagan
Journal:  Saudi J Biol Sci       Date:  2014-04-23       Impact factor: 4.219

7.  Non-Pharmacological Treatments for ADHD in Youth.

Authors:  Anup Sharma; Patricia L Gerbarg; Richard P Brown
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2015

Review 8.  Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements.

Authors:  Lily Dara; Jennifer Hewett; Joseph Kartaik Lim
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

9.  Binding to WGR domain by salidroside activates PARP1 and protects hematopoietic stem cells from oxidative stress.

Authors:  Xue Li; Ozlem Erden; Liang Li; Qidong Ye; Andrew Wilson; Wei Du
Journal:  Antioxid Redox Signal       Date:  2014-03-05       Impact factor: 8.401

10.  Involvement of ERK1/2 pathway in neuroprotection by salidroside against hydrogen peroxide-induced apoptotic cell death.

Authors:  Shu Yu; Yuntian Shen; Jie Liu; Fei Ding
Journal:  J Mol Neurosci       Date:  2009-09-29       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.